Cover Image
市場調查報告書

Tetra Discovery Partners LLC:產品平台分析

Tetra Discovery Partners LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 319998
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Tetra Discovery Partners LLC:產品平台分析 Tetra Discovery Partners LLC - Product Pipeline Review - 2015
出版日期: 2015年12月16日 內容資訊: 英文 22 Pages
簡介

Tetra Discovery Partners LLC 是致力發現與開發精神疾病和神經疾病治療藥的生物科技企業。 基於結構資訊採用藥物設計的科學性方法開發對PDE4亞型的變構抑制劑。還有該公司的開發平台主要由老年癡呆症、憂鬱症、創傷性腦損傷治療3個藥物候補所構成,主要的化合物有設計給從初期到中度的老年癡呆症的記憶力衰退治療用的藥物。

本報告提供Tetra Discovery Partners LLC的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Tetra Discovery Partners LLC的基本資料

  • Tetra Discovery Partners LLC概要
  • 主要資訊
  • 企業資料

Tetra Discovery Partners LLC:R&D概要

  • 主要的治療範圍

Tetra Discovery Partners LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Tetra Discovery Partners LLC:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Tetra Discovery Partners LLC:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Tetra Discovery Partners LLC:藥物簡介

  • Small Molecule to Inhibit PDE4 for Alzheimer's Disease
  • Small Molecule to Inhibit PDE4 for Depression
  • Small Molecule to Inhibit PDE4 for Traumatic Brain Injury
  • Small Molecules to Inhibit PDE4D for Schizophrenia

Tetra Discovery Partners LLC:開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Tetra Discovery Partners LLC:最近的開發平台趨勢

Tetra Discovery Partners LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07882CDB

Summary

Global Markets Direct's, 'Tetra Discovery Partners LLC - Product Pipeline Review - 2015', provides an overview of the Tetra Discovery Partners LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tetra Discovery Partners LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Tetra Discovery Partners LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Tetra Discovery Partners LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Tetra Discovery Partners LLC's pipeline products

Reasons to buy

  • Evaluate Tetra Discovery Partners LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Tetra Discovery Partners LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Tetra Discovery Partners LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Tetra Discovery Partners LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tetra Discovery Partners LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Tetra Discovery Partners LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Tetra Discovery Partners LLC Snapshot
    • Tetra Discovery Partners LLC Overview
    • Key Information
    • Key Facts
  • Tetra Discovery Partners LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Tetra Discovery Partners LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Tetra Discovery Partners LLC - Pipeline Products Glance
    • Tetra Discovery Partners LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Tetra Discovery Partners LLC - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Tetra Discovery Partners LLC - Drug Profiles
    • BPN-14770
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DG-071
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • T-094
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit PDE4D for Schizophrenia
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Tetra Discovery Partners LLC - Pipeline Analysis
    • Tetra Discovery Partners LLC - Pipeline Products by Target
    • Tetra Discovery Partners LLC - Pipeline Products by Molecule Type
    • Tetra Discovery Partners LLC - Pipeline Products by Mechanism of Action
  • Tetra Discovery Partners LLC - Recent Pipeline Updates
  • Tetra Discovery Partners LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Tetra Discovery Partners LLC, Key Information
  • Tetra Discovery Partners LLC, Key Facts
  • Tetra Discovery Partners LLC - Pipeline by Indication, 2015
  • Tetra Discovery Partners LLC - Pipeline by Stage of Development, 2015
  • Tetra Discovery Partners LLC - Monotherapy Products in Pipeline, 2015
  • Tetra Discovery Partners LLC - Preclinical, 2015
  • Tetra Discovery Partners LLC - Discovery, 2015
  • Tetra Discovery Partners LLC - Unknown, 2015
  • Tetra Discovery Partners LLC - Pipeline by Target, 2015
  • Tetra Discovery Partners LLC - Pipeline by Molecule Type, 2015
  • Tetra Discovery Partners LLC - Pipeline Products by Mechanism of Action, 2015
  • Tetra Discovery Partners LLC - Recent Pipeline Updates, 2015

List of Figures

  • Tetra Discovery Partners LLC - Pipeline by Top 10 Indication, 2015
  • Tetra Discovery Partners LLC - Pipeline by Stage of Development, 2015
  • Tetra Discovery Partners LLC - Monotherapy Products in Pipeline, 2015
  • Tetra Discovery Partners LLC - Pipeline by Top 10 Target, 2015
  • Tetra Discovery Partners LLC - Pipeline by Top 10 Molecule Type, 2015
  • Tetra Discovery Partners LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top